Azenta (BSP:A2ZT34) Other Financing: R$-257 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:A2ZT34 Azenta Inc BSP:A2ZT34
54 GF Score
Price R$14.16
GF Value R$19.22
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Azenta Other Financing?

Azenta BSP:A2ZT34 54 Other Financing is R$-257 Mil as of Jun. 2026. GuruFocus rates BSP:A2ZT34 with a GF Score™ of 54/100 and a GF Value™ of R$19.22 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Azenta's Other Financing for the three months ended in Jun. 2026 was R$-257 Mil.

Azenta's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was R$-257 Mil.

Azenta Other Financing Historical Data

* Premium members only.

The historical data trend for Azenta's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Azenta Other Financing Chart

Azenta Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -54.53 -24.63 0.00 -61.01

Azenta Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6.53 -13.19 6.16 -256.96
BSP:A2ZT34
54GF Score
Azenta Inc BSP:A2ZT34
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Azenta Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-257 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of R$-257 Mil mean?
Azenta (BSP:A2ZT34) has a Other Financing of R$-257 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Azenta and its competitors.
Is Azenta's Other Financing too high?
Azenta's current Other Financing is R$-257 Mil. Overall, Azenta has a GF Score™ of 54/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Azenta's Other Financing compare to KMTS and STAA?
Azenta's Other Financing of R$-257 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Azenta and its competitors. Azenta's current Other Financing is R$-257 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (BSP:A2ZT34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$19.22, compared to a current price of R$14.16 — trading 26.3% below its estimated fair value. The current Other Financing is R$-257 Mil. Azenta's overall GF Score™ is 54/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Azenta (BSP:A2ZT34), the current Other Financing is R$-257 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Azenta (BSP:A2ZT34) Overvalued in 2026?

Based on GuruFocus' analysis, Azenta stock appears to be undervalued. The current stock price of R$14.16 is trading 26.3% below its estimated GF Value™ of R$19.22. GuruFocus considers Azenta to be Modestly Undervalued.

Key valuation signals for BSP:A2ZT34:

  • Other Financing: R$-257 Mil
  • GF Value™: R$19.22 vs. price of R$14.16 (26.3% below fair value)
  • GF Score™: 54/100 with 1 warning sign

No single metric tells the full story. See the BSP:A2ZT34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Azenta Business Description

Other Exchanges AZTA:USA0HQ1:UKBA3:Germany
Address 200 Summit Drive, 6th Floor, Burlington, MA, USA, 01803
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
54GF Score

Get the complete analysis for BSP:A2ZT34

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$14.16
Price
R$19.22
GF Value